日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association Between Epstein-Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications

Epstein-Barr病毒感染与胃癌中PD-L1表达的相关性：患病率、临床病理特征和预后意义

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17091492
Wonglhow, Jirapat; Tantipisit, Jarukit; Wetwittayakhlang, Panu; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Kanjanapradit, Kanet; Thongwatchara, Phatcharaporn; Dechaphunkul, Arunee
胃癌
肿瘤
肿瘤免疫
炎症/感染
微生物学
PD-L1
发表日期：2025
文献求助 收藏

Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study

HER2低表达与HER2零表达的HR阳性转移性乳腺癌患者接受内分泌治疗（联合或不联合CDK4/6抑制剂）的临床结局：一项多中心回顾性研究

期刊:International Journal of Breast Cancer
影响因子:3
doi:10.1155/ijbc/5597051
Susiriwatananont, Thiti; Wongkraisri, Concord; Dajsakdipon, Thanate; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Ithimakin, Suthinee; Dejthevaporn, Thitiya; Parinyanitikul, Napa
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Role of Adjuvant Chemotherapy in Resected Small Bowel Adenocarcinoma: An Exploratory Real-World Analysis of Survival Outcomes and Prognostic Factors

辅助化疗在切除小肠腺癌中的作用：生存结果和预后因素的探索性真实世界分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14217513
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee; Wetwittayakhlang, Panu
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A 20-Year Real-World Study of Small Bowel Cancers: Histologic Subtypes, Clinical Features, and Survival Implications

一项为期 20 年的小肠癌真实世界研究：组织学亚型、临床特征和生存意义

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14196962
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee; Wetwittayakhlang, Panu
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Trends in Cancer Diagnoses Among People Living with HIV: A 20-Year Retrospective Study from a Tertiary Center in Thailand

泰国一家三级医疗中心20年回顾性研究：艾滋病毒感染者癌症诊断趋势

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15010022
Wonglhow, Jirapat; Chaiwiriyawong, Supakorn; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee
肿瘤
肿瘤免疫
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Effectiveness of Palliative Chemotherapy and Associated Prognostic Factors in Advanced Small Bowel Adenocarcinoma: A Propensity Score-Matched Analysis

姑息性化疗对晚期小肠腺癌疗效及相关预后因素的影响：倾向评分匹配分析

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S558642
Wonglhow, Jirapat; Dechaphunkul, Arunee; Sathitruangsak, Chirawadee; Sunpaweravong, Patrapim; Wetwittayakhlang, Panu
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Sarcopenia following concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

局部晚期食管鳞状细胞癌同步放化疗后肌少症

期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-2025-87
Vongcharoenpol, Thiranai; Chaochankit, Wongsakorn; Ruangsin, Sakchai; Laohawiriyakamol, Supparerk; Leelakiatpaiboon, Siriporn; Ina, Natee; Kittichet, Rungarun; Sunpaweravong, Patrapim; Sunpaweravong, Somkiat
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer

KEYNOTE-590研究中与健康相关的生活质量分析：帕博利珠单抗联合化疗与单纯化疗治疗晚期食管癌

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae087
Mansoor, Wasat; Joo, Seongjung; Norquist, Josephine M; Kato, Ken; Sun, Jong-Mu; Shah, Manish A; Enzinger, Peter; Adenis, Antoine; Doi, Toshihiko; Kojima, Takashi; Metges, Jean-Philippe; Li, Zhigang; Kim, Sung-Bae; Cho, Byoung Chol; Sunpaweravong, Patrapim; Alsina, Maria; Goekkurt, Eray; Suryawanshi, Shailaja; Shah, Sukrut; Shen, Lin
食管癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

LABS score- a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

LABS评分——FOLFOX4治疗晚期肝细胞癌的预后工具及其真实世界疗效：一项单中心回顾性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12040-z
Wonglhow, Jirapat; Sunpaweravong, Patrapim; Sathitruangsak, Chirawadee; Dechaphunkul, Arunee
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand

比较帕博西尼或瑞博西尼联合AI治疗HR+/HER2-晚期乳腺癌患者的生存疗效（CEPRA研究）：来自泰国的真实世界数据的初步分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12765-x
Dajsakdipon, Thanate; Susiriwatananont, Thiti; Wongkraisri, Concord; Ithimakin, Suthinee; Parinyanitikul, Napa; Supavavej, Archara; Dechaphunkul, Arunee; Sunpaweravong, Patrapim; Neesanun, Sunee; Akewanlop, Charuwan; Dejthevaporn, Thitiya
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏